CAS: 221092-61-1

2'-Bromo-2'-deoxyadenosine-5'-[(beta,gamma)-imido]triphosphate triethylammonium salt (IDP) is a synthetic analog of adenosine that has been used as a bioreactor in tissue culture. IDP binds to the mineralocorticoid receptor and activates it, leading to increased levels of fatty acid synthesis in the blood sample. This drug has shown efficacy in treating cancer and inhibiting tumor growth in animal studies. IDP also has potential for use as an environmental pollutant due to its ability to be activated by wastewater treatment processes.